Myostatin as a therapeutic target in Amyotrophic Lateral Sclerosis
Authors:
- Frank S. WalshFWFrank S. Walsh
- Julia Lynn RutkowskiJRJulia Lynn Rutkowski
- 1 November 2012
- journal article
- review article
- Published by Elsevier in Neurochemistry International
- Vol. 61 (6) , 931-935
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- New drugs for ALS: How do we get there?Experimental Neurology, 2012
- Dissection of the IgNAR V Domain: Molecular Scanning and Orthologue Database Mining Define Novel IgNAR Hallmarks and Affinity Maturation MechanismsJournal of Molecular Biology, 2010
- Receptors for myelin inhibitors: Structures and therapeutic opportunitiesMolecular and Cellular Neuroscience, 2010
- Protein Pharmaceuticals: Discovery and Preclinical Development2009
- Myostatin as a therapeutic target for musculoskeletal diseaseCellular and Molecular Life Sciences, 2008
- Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosisNeurobiology of Disease, 2006
- Amyotrophic Lateral SclerosisDrugs, 1996
- A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharksNature, 1995
- Monoclonal antibody to a plasma membrane antigen of neurons.Proceedings of the National Academy of Sciences, 1979
- Synapse Formation Between Two Clonal Cell LinesScience, 1977